Pioglitazone

Hmm… We’d better think about this again. Pioglitazone is not a good first‑line choice because it causes weight gain and fluid retention and it lacks clear cardiovascular outcome benefits. If a thiazolidinedione is considered at all, it is considered in cases where first line drugs are not indicated or unavailable, or in combination with other first line drugs.

Try to think about other drugs with favourable weight and cardiovascular profiles. Always consider the full clinical context when prescribing medications and try again!

  • Order a karyotype [undo]
  • Λάθος! [undo]
  • Definiția 2 [undo]
  • Glyceryl trinitrate (organic nitrate) [undo]
  • Labs [undo]
  • Самолікуватися — це вихід. Рослинні або заспокійливі препарати підійдуть. [undo]
  • Rely on physical traits [undo]
  • Лікування веде до поліпшення. [undo]
  • Presentation [undo]
  • Insulin [undo]
  • Molecular Cloning [undo]
  • Πρωτεϊνοσύνθεση [undo]
  • Definition 1 [undo]
  • Ορισμός 2 [undo]
  • A microscope that uses light source to magnify objects [undo]
  • Empagliflozin [undo]
  • Increased secretion of insulin from the pancreas [undo]
  • Virtual Patient Scenario: Maria's Telemonitoring Empowerment Journey [undo]
  • Ask rapid questions using medical jargon (ischemia, necrotic tissue, perfusion). [undo]
  • Ei syödä [undo]
  • Use only Mendelian probability [undo]
  • Εισαγωγή για θεραπευτική αντιμετώπιση [undo]
  • Pioglitazone [undo]

Map: Michael Green_GEMD_2 (1116)
Node: 21115
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway